Geode Capital Management
PRAX icon

Geode Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Geode Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250M Buy
748,039
+97,135
+15% +$30.7M 0.01% 705
2026
Q1 		$210M Buy
650,904
+88,525
+16% +$27.4M 0.01% 716
2025
Q4 		$166M Buy
562,379
+105,347
+23% +$19.6M 0.01% 792
2025
Q3 		$24.2M Buy
457,032
+5,301
+1% +$257K ﹤0.01% 1902
2025
Q2 		$19M Buy
451,731
+33,715
+8% +$1.28M ﹤0.01% 1986
2025
Q1 		$15.8M Buy
418,016
+11,305
+3% +$706K ﹤0.01% 2026
2024
Q4 		$31.3M Buy
406,711
+7,873
+2% +$570K ﹤0.01% 1708
2024
Q3 		$23M Buy
398,838
+3,779
+1% +$204K ﹤0.01% 1913
2024
Q2 		$16.3M Buy
395,059
+260,342
+193% +$12.3M ﹤0.01% 2042
2024
Q1 		$8.22M Buy
134,717
+41,759
+45% +$1.87M ﹤0.01% 2439
2023
Q4 		$2.07M Buy
92,958
+6,412
+7% +$115K ﹤0.01% 3091
2023
Q3 		$2.22M Buy
86,546
+56,993
+193% +$1.08M ﹤0.01% 3042
2023
Q2 		$510K Sell
29,553
-26,152
-47% -$400K ﹤0.01% 3632
2023
Q1 		$676K Buy
55,705
+9,466
+20% +$400K ﹤0.01% 3535
2022
Q4 		$1.65M Buy
46,239
+3,925
+9% +$122K ﹤0.01% 3130
2022
Q3 		$1.44M Sell
42,314
-146
-0.3% -$7.28K ﹤0.01% 3213
2022
Q2 		$1.56M Buy
42,460
+641
+2% +$68.4K ﹤0.01% 3207
2022
Q1 		$6.4M Buy
41,819
+1,993
+5% +$409K ﹤0.01% 2643
2021
Q4 		$11.8M Buy
39,826
+876
+2% +$257K ﹤0.01% 2338
2021
Q3 		$10.8M Buy
38,950
+16,016
+70% +$4.34M ﹤0.01% 2405
2021
Q2 		$6.29M Buy
22,934
+8,923
+64% +$3.2M ﹤0.01% 2767
2021
Q1 		$6.88M Buy
14,011
+341
+2% +$242K ﹤0.01% 2615
2020
Q4 		$11.3M Buy
+13,670
New +$7.98M ﹤0.01% 2084

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management's PRAX Position: Q2 2026 in Review

Geode Capital Management increased its Praxis Precision Medicines (PRAX) stake by 15% in Q2 2026, buying an estimated $30.7M and bringing the position to 748,039 shares worth $250M. The position accounts for 0.01% of the portfolio, ranked #705.

Geode Capital Management first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Geode Capital Management held 748,039 shares of Praxis Precision Medicines worth $250M as of Q2 2026.
  • Geode Capital Management bought 97,135 Praxis Precision Medicines shares in Q2 2026, an estimated $30.7M.
  • Praxis Precision Medicines made up 0.01% of Geode Capital Management's portfolio in Q2 2026, its #705 holding.
  • Geode Capital Management first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.